E. F. Smith

发表

Montenay recyclable trash improvements (RTI) project

D. M. Smith, E. F. Smith, 1998 .

Screening contact materials for low speed slip ring assemblies

R. Lysonski, J. W. Agopovich, E. F. Smith, 1993, Proceedings of IEEE Holm Conference on Electrical Contacts.

Caustic-free jet fuel Merox unit reduces waste disposal

E. F. Smith, P. R. Cressman, M. L. Hurren, 1995 .

Design Guidelines for Automotive Fuel Level Sensors

E. F. Smith, Hugh W. Ireland, 2002 .

Salutary effects of prostacyclin in endotoxic shock.

E. F. Smith, A. M. Lefer, A. Lefer, 1980, Pharmacology.

In vitro antimicrobial efficacy of riboflavin and ultraviolet light on Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, and Pseudomonas aeruginosa.

E. F. Smith, S. Trokel, A. Schrier, 2009, Journal of refractive surgery.

Reduction of myocardial reperfusion injury with human soluble complement receptor type 1 (BRL 55730).

E. F. Smith, R. Smith, J. Egan, 1993, European journal of pharmacology.

Infarct size restriction in cats by the β-adrenergic blocker timolol

E. F. Smith, A. M. Lefer, A. Lefer, 1982 .

Early and late administration of a PGI2-analogue, ZK 36 374 (iloprost): effects on myocardial preservation, collateral blood flow and infarct size.

E. F. Smith, K. Schrör, T. Thomsen, 1984, Cardiovascular research.

Mechanism of coronary vasoconstriction induced by carbocyclic thromboxane A2.

E. F. Smith, A. Lefer, K. C. Nicolaou, 1981, The American journal of physiology.

ω-Halofatty acids: A probe for mitochondrial membrane integrity

E. F. Smith, K. Schrör, G. Stöcklin, 1984, European Journal of Nuclear Medicine.

Regression of Presumed Primary Conjunctival and Corneal Intraepithelial Neoplasia With Topical Interferon Alpha-2b

E. F. Smith, A. Schrier, B. Schechter, 2002, Cornea.

Effects of prostaglandins on distribution of blood flow in the cat.

E. F. Smith, A. M. Lefer, A. Lefer, 1978, Prostaglandins and medicine.

Effects of arachidonic acid hydroperoxides on vascular and non-vascular smooth muscle.

E. F. Smith, A. M. Lefer, A. Lefer, 1981, Prostaglandins and medicine.

SK&F S‐106203 inhibits leukotriene C4, leukotriene D4 and leukotriene E4 vasopressor responses in the conscious rat

E. F. Smith, M. Slivjak, J. Egan, 1990, British journal of pharmacology.

Synthesis and biological properties of pinane-thromboxane A2, a selective inhibitor of coronary artery constriction, platelet aggregation, and thromboxane formation.

E. F. Smith, A. M. Lefer, R. Magolda, 1979, Proceedings of the National Academy of Sciences of the United States of America.

Stabilization of cardiac lysosomal and cellular membranes in protection of ischemic myocardium due to coronary occlusion:efficacy of the nonsteroidal anti-inflammatory agent, naproxen.

E. F. Smith, A. M. Lefer, A. Lefer, 1981, American heart journal.

Beneficial actions of imidazole in endotoxin shock.

E. F. Smith, A. M. Lefer, A. Lefer, 1980, Prostaglandins and medicine.

Polyuria in patients with lower urinary tract symptoms: Prevalence and etiology

E. F. Smith, J. Blaivas, J. Weiss, 2022, Neurourology and urodynamics.

Thromboxane synthetase inhibitors differentially antagonize thromboxane receptors in vascular smooth muscle

E. F. Smith, A. Lefer, K. C. Nicolaou, 1981, Naunyn-Schmiedeberg's Archives of Pharmacology.

Influence of thromboxane inhibition on the severity of myocardial ischemia in cats.

E. F. Smith, A. M. Lefer, A. Lefer, 1980, Canadian journal of physiology and pharmacology.

Interaction of eicosanoids and macrophages during inflammatory responses

E. F. Smith, P. Halushka, J. Cook, 1984, Survey of immunologic research.

CGS 15435A, a thromboxane synthetase inhibitor with an extended duration of action: a comparison with dazoxiben.

E. F. Smith, E. Ku, D. Cohen, 1987, European journal of pharmacology.

A Review of Needle‐Free Sumatriptan Injection for Rapid Control of Migraine

E. F. Smith, J. Rothrock, F. Freitag, 2013, Headache.

Primate vascular responses to octimibate, a non‐prostanoid agonist at the prostacyclin receptor

E. F. Smith, T. Rink, A. Heagerty, 1991, British journal of pharmacology.

Beneficial effects of a new thromboxane synthetase inhibitor in arachidonate-induced sudden death.

E. F. Smith, A. M. Lefer, S. Okamatsu, 1981, Thrombosis research.

Evaluation of the cardiovascular effects of arecoline in the anesthetized dog

E. F. Smith, H. Shlevin, F. R. Goodman, 1986 .

Can intraocular lenses deliver antibiotics intracamerally?

E. F. Smith, R. U. Desai, A. Schrier, 2010, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Leukotrienes in Endotoxic and Septic Shock

E. F. Smith, C. Turner, 2019, Handbook of Mediators in Septic Shock.

Characterization of cAMP-dependent inhibition of LPS-induced TNF alpha production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitor.

E. F. Smith, John C. Lee, J. Lee, 1994, International journal of immunopharmacology.

Myocardial protection with carvedilol.

E. F. Smith, G. Feuerstein, E. Smith, 1992, Journal of cardiovascular pharmacology.

Identification of cardiac endothelin binding sites in rats: downregulation of left atrial endothelin binding sites in response to myocardial infarction.

E. F. Smith, P. Nambi, J. Egan, 1991, Pharmacology.